Injective price jumps as token buying pressure builds

Injective price jumps as token buying pressure builds
Injective surges 15.97% today to $4.06

Injective (INJ) is trading at $4.06 after surging 15.97% on the day, maintaining its position above the 20-day and 50-day moving averages, which signals continued short- and medium-term upward momentum. The price remains below the 200-day moving average at $4.90, showing that longer-term resistance persists.

INJ price prediction
24H -4.4%
$4.13
48H -6.71%
$4.03
7D -24.31%
$3.27
1M 8.33%
$4.68
3M 144.68%
$10.57
6M 113.19%
$9.21
12M 92.82%
$8.33
Current price: $ 4.32 -0.26 5.58%
Real-time Data 13:41
Daily range 4.27 Arrow from to Icon 4.59
Weekly range 4.51 Arrow from to Icon 5.53
Loading...

Highlights

  • Injective's deflationary tokenomics, including fee-based burns and staking, support gradual reduction in overall token supply.
  • Ongoing discussions about institutional interest and ETF applications may influence long-term sentiment and adoption.
  • INJ/USD shows robust short-term momentum and strong intraday buying, but overbought conditions and weak weekly signals imply risk of near-term consolidation between $3.20 and $4.63.

Supply contraction and staking utility bolster outlook amid ETF speculation

Injective’s tokenomics feature mechanisms such as staking, governance, and a deflationary burn process where a portion of dApp fees are used to repurchase and permanently remove tokens from circulation, contributing to a reduced overall supply. The use of auction fees for burning and ongoing staking utility supports the network’s deflationary model. Discussions regarding ETF filings and institutional involvement have been mentioned as influencing the long-term outlook.

Anton Kharitonov, expert at Traders Union, notes that Injective is showing strong intraday momentum but faces firm resistance from the 200-day moving average. He sees that key oscillators have reached fully overbought territory, and the ADX reads weak trend strength. Sentiment has improved on deflationary tokenomics and network utility, but Kharitonov calls attention to the lack of bullish signals across weekly indicators. He cautions that downside risk is significant if $3.20 fails to hold, especially given the overshot daily move and underlying long-term resistance. "The current setup looks stretched, and without confirmation from higher timeframes, traders should remain defensive and avoid chasing this rally."

Viktoras Karapetjanc, expert at Traders Union, sees the bullish structure as intact for Injective after today's impressive 15.97% gain. He highlights that deflationary tokenomics, effective staking, and speculation about institutional involvement are building strong fundamental backing. Karapetjanc stresses that ongoing fee burns and strategic network incentives support further growth, even if some oscillators flag consolidation risk. He is confident that, despite short-term resistance, the market offers promising setups for trend continuation. "With fundamentals this strong and momentum in place, I expect further upside as opportunities for investors widen."

Parshwa Turakhiya, analyst, recognizes strong buyer dominance and rising sentiment behind INJ/USD. He points out that the asset is testing resistance near $4.50, with momentum robust but daily indicators stretched. The short-term setup favors swing trades exploiting heightened volatility, but a pullback to $3.20 is possible if momentum cools. He analyzes that risk and opportunity are finely balanced at these levels. "Traders should watch for breakout confirmation before pressing bullish bets, as the risk of reversal is equally present."

Intraday strength persists as overbought signals threaten pullback

INJ/USD is trading above its 20-day and 50-day moving averages at $3.16 and $3.05, respectively, which confirms short- and medium-term upward momentum. The price remains under its 200-day moving average at $4.90, indicating lingering long-term resistance, while the nearest dynamic support is seen near the Ichimoku Kijun level around $3.20; the next resistance is at the round $4.50 area.

Daily momentum is firm, with the Moving Average Convergence Divergence (MACD) showing a buy signal and the Average Directional Index (ADX) still at a low 13.25, suggesting the trend lacks strong conviction. The Relative Strength Index (RSI) is approaching overbought at 66.97, and both the Stochastic RSI and Commodity Channel Index (CCI) are fully overbought, indicating short-term risk of pullback or consolidation. Bull/Bear Power (BBP) at 0.38 shows buyers clearly dominate intraday, even as oscillators flag a stretched move. The Awesome Oscillator (AO) supports the positive sentiment. The pair jumped at the open with an upside gap of about $0.04, surged 15.97% on the day to $4.06, and is trading near session highs. Intraday volatility stands at 16.24%, reflecting strong buying pressure persisting beyond the open. Momentum indicators and daily price action both confirm robust intraday strength, but overbought oscillators warn of emerging risks for short-term traders.

Earlier, analysts noted that although Injective showed some signs of short-term recovery, the broader outlook remained cautious due to persistent medium- and long-term bearish signals. The latest surge in price and sustained intraday momentum adds a new dimension to the analysis, but with overbought conditions emerging and weekly indicators still bearish, traders should monitor the $4.63 resistance level for a potential breakout or be prepared for a possible corrective pullback.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.